keyword
https://read.qxmd.com/read/38643675/genomic-analysis-of-a-novel-phage-vb_sens_st1unam-with-lytic-activity-against-salmonella-enterica-serotypes
#21
JOURNAL ARTICLE
Gerardo E Rodea M, Edgar González-Villalobos, María Del Rosario Espinoza-Mellado, Ulises Hernández-Chiñas, Carlos Alberto Eslava-Campos, José Luis Balcázar, José Molina-López
In this study, we present the complete annotated genome of a novel Salmonella phage, vB_SenS_ST1UNAM. This phage exhibits lytic activity against several Salmonella enterica serotypes, such as S. Typhi, S. Enteritidis, and S. Typhimurium strains, which are major causes of foodborne illness worldwide. Its genome consists of a linear, double-stranded DNA of 47,877 bp with an average G+C content of 46.6%. A total of 85 coding regions (CDS) were predicted, of which only 43 CDS were functionally assigned. Neither genes involved in the regulation of lysogeny, nor antibiotic resistance genes were identified...
April 15, 2024: Diagnostic Microbiology and Infectious Disease
https://read.qxmd.com/read/38643211/undifferentiated-carcinoma-of-the-liver-with-osteoclast-like-giant-cells-a-case-report-and-literature-review
#22
REVIEW
Lixia Lu, Li Wang, Can Peng, Li Chen, Ximan He, Chenning Shao, Chunnian Wang, Rong Ge
Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver. Osteoclast-like giant cells (OGCs) are relatively more common in pancreatic cancer, but extremely rare in HCC. Currently, there have been only a few reported cases of OGCs in HCC, and their presence indicates an aggressive clinical course. Here, we present a case of primary undifferentiated carcinoma of the liver with OGCs in a 49-year-old male patient, and through a literature review, we summarize 20 similar cases to further understand the diagnosis, treatment, and clinical course of this disease entity...
April 20, 2024: Infectious Agents and Cancer
https://read.qxmd.com/read/38643090/genomycanalyzer-a-web-based-tool-for-species-and-drug-resistance-prediction-for-mycobacterium-genomes
#23
JOURNAL ARTICLE
Doyoung Kim, Jeong-Ih Shin, In Young Yoo, Sungjin Jo, Jiyon Chu, Woo Young Cho, Seung-Hun Shin, Yeun-Jun Chung, Yeon-Joon Park, Seung-Hyun Jung
BACKGROUND: Drug-resistant tuberculosis (TB) is a major threat to global public health. Whole-genome sequencing (WGS) is a useful tool for species identification and drug resistance prediction, and many clinical laboratories are transitioning to WGS as a routine diagnostic tool. However, user-friendly and high-confidence automated bioinformatics tools are needed to rapidly identify M. tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM), detect drug resistance, and further guide treatment options...
April 20, 2024: BMC Genomics
https://read.qxmd.com/read/38642906/optimizing-clinical-outcomes-for-bronchoscopic-lung-volume-reduction-with-zephyr%C3%A2-valves
#24
REVIEW
T David Koster, Pallav L Shah, Arschang Valipour, Gerard J Criner, Felix J F Herth, Richard Sue, Douglas K Hogarth, Ralitza T Martin, Amit K Mahajan, Raed Alalawi, Lisa Kopas, Avi Cohen, Douglas E Wood, Jonathan Kurman, Narinder S Shargill, Mark Dransfield, Dirk-Jan Slebos, Michael Perch
Bronchoscopic lung volume reduction treatment with Zephyr one-way valves is an effective guideline-based treatment option for patients with severe emphysema and hyperinflation. However, in some cases the treatment response is less than anticipated or there might be a loss of initial treatment effect. Reasons for the lack of response can include incorrect assessment of collateral ventilation, improper valve placement, or patient related factors. Loss of initial benefit can be due to granulation tissue formation and subsequent valve dysfunction, or there may be side effects such as excessive coughing or infectious problems...
April 18, 2024: Respiratory Medicine
https://read.qxmd.com/read/38642895/persistent-covid-19-in-immunocompromised-patients-israeli-society-of-infectious-diseases-consensus-statement-on-diagnosis-and-management
#25
REVIEW
Suzy E Meijer, Yael Paran, Ana Belkin, Ronen Ben-Ami, Yasmin Maor, Lior Nesher, Khetam Hussein, Galia Rahav, Tal Brosh-Nissimov
BACKGROUND: Immunocompromised patients with impaired humoral immunity are at risk for persistent COVID-19 (pCOVID), a protracted symptomatic disease with active viral replication. OBJECTIVES: To establish a national consensus statement on the diagnosis, treatment, management, isolation, and prevention of pCOVID in adults. SOURCES: We base our suggestions on the available literature, our own experience and clinical reasoning. CONTENT: Literature on the treatment of pCOVID is scarce and consists of few case-reports and case series...
April 18, 2024: Clinical Microbiology and Infection
https://read.qxmd.com/read/38642828/virus-induced-diabetes-mellitus-revisiting-infection-etiology-in-light-of-sars-cov-2
#26
REVIEW
Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E Butler
Diabetes mellitus (DM) is comprised of two predominant subtypes: type 1 diabetes mellitus (T1DM), accounting for approximately 5 % of cases worldwide and resulting from autoimmune destruction of insulin-producing β-cells, and type 2 (T2DM), accounting for approximately 95 % of cases globally and characterized by the inability of pancreatic β-cells to meet the demand for insulin due to a relative β-cell deficit in the setting of peripheral insulin resistance. Both types of DM involve derangement of glucose metabolism and are metabolic diseases generally considered to be initiated by a combination of genetic and environmental factors...
April 18, 2024: Metabolism: Clinical and Experimental
https://read.qxmd.com/read/38642804/broken-but-not-beaten-challenge-of-reducing-the-amyloids-pathogenicity-by-degradation
#27
REVIEW
Maksim I Sulatsky, Olga V Stepanenko, Olesya V Stepanenko, Olga I Povarova, Irina M Kuznetsova, Konstantin K Turoverov, Anna I Sulatskaya
BACKGROUND: The accumulation of ordered protein aggregates, amyloid fibrils, accompanies various neurodegenerative diseases (such as Parkinson's, Huntington's, Alzheimer's, etc.) and causes a wide range of systemic and local amyloidoses (such as insulin, hemodialysis amyloidosis, etc.). Such pathologies are usually diagnosed when the disease is already irreversible and a large amount of amyloid plaques have accumulated. In recent years, new drugs aimed at reducing amyloid levels have been actively developed...
April 18, 2024: Journal of Advanced Research
https://read.qxmd.com/read/38642698/trends-and-clinical-outcomes-of-fungal-keratitis-in-canada-a-20-year-retrospective-multicentre-study
#28
JOURNAL ARTICLE
Jennifer Ym Ling, Sonia N Yeung, Clara Chan, Tanya Trinh, Fares Antaki, Mona Harissi-Dagher, Nirojini Sivachandran, Mark Fava, Marie-Eve Legare, Alfonso Iovieno
PURPOSE: An increase in fungal and particularly filamentous keratitis has been observed in many geographic areas, mostly in contact lens wearers. This study seeks to characterize long-term trends in fungal keratitis in a continental climate area to provide guidance for diagnosis and treatment. DESIGN: Retrospective multicentric case series. METHODS: Cases of microbiology-confirmed fungal keratitis from 2003 to 2022 presenting to tertiary care centers across Canada were included...
April 18, 2024: American Journal of Ophthalmology
https://read.qxmd.com/read/38642546/serological-evaluation-of-recombinant-protein-antigen-tp0608-for-the-diagnosis-of-syphilis
#29
JOURNAL ARTICLE
Yingying Lu, Qi Wu, Li Wang, Lingting Ji
OBJECTIVE: To evaluate the serological diagnosis value of recombinant protein antigen Tp0608 for syphilis. METHOD: 406 patients with various stages of syphilis were enrolled. A recombinant protein antigen Tp0608 was established and ELISA was used to detect patients with various stages of syphilis. The results were compared with the conventional rapid plasma reagin test (RPR) and Treponema pallidum particle agglutination test (TPPA). The sensitivity of Tp0608 recombinant protein and RPR+TPPA screening was 96...
April 19, 2024: Diagnostic Microbiology and Infectious Disease
https://read.qxmd.com/read/38642403/long-term-risk-of-serious-infections-and-mortality-among-patients-surviving-drug-use-associated-infective-endocarditis
#30
JOURNAL ARTICLE
Mary C Figgatt, David L Rosen, Vivian H Chu, Li-Tzy Wu, Asher J Schranz
Among a statewide cohort of 1,874 patients surviving hospitalization for drug use-associated endocarditis during 2017-2020, the 3-year risk of death or future hospitalization was 38% (16% for death prior to later infection, 14% for recurrent endocarditis, 14% for soft-tissue, 9% for bacteremia, 5% for bone/joint, and 4% for spinal infections).
April 20, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38642339/association-between-the-number-of-symptomatic-mpox-cases-and-the-detection-of-mpox-virus-dna-in-wastewater-in-switzerland-an-observational-surveillance-study
#31
JOURNAL ARTICLE
Claudia Bagutti, Monica Alt Hug, Philippe Heim, Evelyn Ilg Hampe, Philipp Hübner, Timothy R Julian, Katrin N Koch, Kerstin Grosheintz, Melanie Kraus, Carla Schaubhut, Rahel Tarnutzer, Eva Würfel, Simon Fuchs, Sarah Tschudin-Sutter
AIM OF THE STUDY: The COVID-19 pandemic has drawn attention to the benefit of wastewater-based epidemiology, particularly when case numbers are underreported. Underreporting may be an issue with mpox, where biological reasons and stigma may prevent patients from getting tested. Therefore, we aimed to assess the validity of wastewater surveillance for monitoring mpox virus DNA in wastewater of a Central European city and its association with official case numbers. METHODS: Wastewater samples were collected between 1 July and 28 August 2022 in the catchment area of Basel, Switzerland, and the number of mpox virus genome copies they contained was determined by real-time quantitative PCR...
March 7, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38642238/underlying-neural-mechanisms-of-cognitive-improvement-in-fronto-striatal-response-inhibition-in-people-living-with-hiv-switching-off-efavirenz-a-randomized-controlled-bold-fmri-trial
#32
JOURNAL ARTICLE
Patrick G A Oomen, Charlotte S Hakkers, Joop E Arends, Guido E L van der Berk, Pascal Pas, Andy I M Hoepelman, Berend J van Welzen, Stefan du Plessis
INTRODUCTION: It is unclear whether neurotoxicity due to the antiretroviral drug efavirenz (EFV) results in neurocognitive impairment in people living with HIV (PLWH). Previously, we found that discontinuing EFV was associated with improved processing speed and attention on neuropsychological assessment. In this imaging study, we investigate potential neural mechanisms underlying this cognitive improvement using a BOLD fMRI task assessing cortical and subcortical functioning. METHODS: Asymptomatic adult PLWH stable on emtricitabine/tenofovirdisoproxil/efavirenz were randomly (1:2) assigned to continue their regimen (n = 12) or to switch to emtricitabine/tenofovirdisoproxil/rilpivirine (n = 28)...
April 20, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38642164/single-cell-transcriptomic-analysis-of-epstein-barr-virus-associated-hemophagocytic-lymphohistiocytosis
#33
JOURNAL ARTICLE
Takako Suzuki, Yoshitaka Sato, Yusuke Okuno, Yuka Torii, Yuto Fukuda, Kazunori Haruta, Makoto Yamaguchi, Yoshiki Kawamura, Asahito Hama, Atsushi Narita, Hideki Muramatsu, Tetsushi Yoshikawa, Yoshiyuki Takahashi, Hiroshi Kimura, Yoshinori Ito, Jun-Ichi Kawada
Epstein-Barr virus (EBV) infection can lead to infectious mononucleosis (EBV-IM) and, more rarely, EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH), which is characterized by a life-threatening hyperinflammatory cytokine storm with immune dysregulation. Interferon-gamma (IFNγ) has been identified as a critical mediator for primary HLH; however, the detailed role of IFNγ and other cytokines in EBV-HLH is not fully understood. In this study, we used single-cell RNA sequencing to characterize the immune landscape of EBV-HLH and compared it with EBV-IM...
April 20, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38641791/immunogenicity-and-safety-of-a-recombinant-covid-19-vaccine-zf2001-as-heterologous-booster-after-priming-with-inactivated-vaccine-in-healthy-children-and-adolescents-aged-3-17-years-an-open-labeled-single-arm-clinical-trial
#34
JOURNAL ARTICLE
Tao Huang, Qianqian Hu, Xiang Zhou, Huaiyu Yang, Wei Xia, Feng Cao, Minglu Deng, Xiaoxue Teng, Fan Ding, Zaixin Zhong, Lidong Gao, Jiufeng Sun, Lihui Gong
Considering that neutralizing antibody levels induced by two doses of the inactivated vaccine decreased over time and had fallen to low levels by 6 months, and homologous and heterologous booster immunization programs have been implemented in adults in China. The booster immunization of recombinant COVID-19 vaccine (ZF2001) after priming with inactivated vaccine in healthy children and adolescents has not been reported. We performed an open-labeled, single-arm clinical trial to evaluate the safety and immunogenicity of heterologous booster immunization with ZF2001 after priming with inactivated vaccine among 240 population aged 3-17 years in China...
April 19, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38641577/cost-utility-analysis-of-palivizumab-for-preventing-respiratory-syncytial-virus-in-preterm-neonates-and-infants-in-colombia
#35
JOURNAL ARTICLE
Jaime E Ordóñez, Victor M Huertas
AIM: Palivizumab has proven effective in reducing hospitalizations, preventing severe illness, improving health outcomes, and reducing healthcare costs for infants at risk of respiratory syncytial virus (RSV) infection. We aim to assess the value of palivizumab in preventing RSV infection in high-risk infants in Colombia, where RSV poses a significant threat, causing severe respiratory illness and hospitalizations. METHODS: We conducted a decision tree analysis to compare five doses of palivizumab with no palivizumab...
April 19, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38641565/key-informant-views-on-potential-acceptability-and-feasibility-of-long-acting-antiretroviral-treatment-for-hiv-in-kenya
#36
JOURNAL ARTICLE
Anne Kaggiah, Catherine N Maina, John Kinuthia, Douglas Barthold, Brett Hauber, Jacinda Tran, Jane M Simoni, Susan M Graham
BACKGROUND: In 2020, 14% of diagnosed persons living with HIV (PLWH) in Kenya were not taking antiretroviral therapy (ART), and 19% of those on ART had unsuppressed viral loads. Long-acting antiretroviral therapy (LA-ART) may increase viral suppression by promoting ART uptake and adherence. We conducted key informant (KI) interviews with HIV experts in Kenya to identify product and delivery attributes related to the acceptability and feasibility of providing LA-ART to PLWH in Kenya. METHODS: Interviews were conducted via Zoom on potential LA-ART options including intra-muscular (IM) injections, subcutaneous (SC) injections, implants, and LA oral pills...
April 19, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38641497/leptospira-specific-immunoglobulin-y-igy-is-protective-in-infected-hamsters
#37
JOURNAL ARTICLE
Tianbao Lv, Xufeng Xie, Luteng Diao, Shuang Jiang, Yue Ding, Xin Yuan, Lingling Gong, Xi Chen, Wenlong Zhang, Yongguo Cao
Leptospirosis, a globally significant zoonotic disease caused by pathogenic Leptospira, continues to threaten the health and public safety of both humans and animals. Current clinical treatment of leptospirosis mainly relies on antibiotics but their efficacy in severe cases is controversial. Passive immunization has a protective effect in the treatment of infectious diseases. In addition, chicken egg yolk antibody (IgY) has gained increasing attention as a safe passive immunization agent. This study aimed to investigate whether hens produce specific IgY after immunization with inactivated Leptospira and the protective effect of specific IgY against leptospirosis...
April 18, 2024: Vaccine
https://read.qxmd.com/read/38641401/frontiers-in-emergency-department-infectious-disease-management
#38
EDITORIAL
Bradley W Frazee, Michael S Pulia, Christopher M Colbert
No abstract text is available yet for this article.
May 2024: Emergency Medicine Clinics of North America
https://read.qxmd.com/read/38641400/infectious-disease-emergencies
#39
EDITORIAL
Amal Mattu
No abstract text is available yet for this article.
May 2024: Emergency Medicine Clinics of North America
https://read.qxmd.com/read/38641399/managing-antimicrobial-resistance-in-the-emergency-department
#40
REVIEW
Julianne Yeary, Larissa Hacker, Stephen Y Liang
(Basic awareness and understanding of antimicrobial resistance and prevailing mechanisms can aid emergency physicians in providing appropriate care to patients with infections due to a multidrug-resistant organism (MDRO). Empiric treatment of MDRO infections should be approached with caution and guided by the most likely pathogens based on differential diagnosis, severity of the illness, suspected source of infection, patient-specific factors, and local antibiotic susceptibility patterns. Newer broad-spectrum antibiotics should be reserved for critically ill patients where there is a high likelihood of infection with an MDRO...
May 2024: Emergency Medicine Clinics of North America
keyword
keyword
43653
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.